Table 2Efficacy of treatment (using lower and upper confidence intervals)

OutcomeMean (95% CI)Lower limit ICERUpper limit ICER
Non-fatal MI0.81 (0.72–0.91)£11,890£15,556
Non-fatal stroke0.82 (0.70–0.96)£11,146£16,747
Non-fatal PAD0.87 (0.69–1.11)£12,464£14,975
Heart Failure0.77 (0.65–0.92)£12,580£14,679
Revascularisation0.78 (0.71–0.86)£12,984£13,968
Unstable Angina0.84 (0.69–0.1.01)£12,430£14,674
CVD mortality0.92 (0.72–1.171)£7,579D**

High intensity is dominated by lower intensity. RR of CVD mortality is 1.17 suggesting there are more deaths in high intensity statin arm.

From: Appendix E, Health Economic modelling

Cover of Identification and Management of Familial Hypercholesterolaemia (FH)
Identification and Management of Familial Hypercholesterolaemia (FH) [Internet].
NICE Clinical Guidelines, No. 71.
National Collaborating Centre for Primary Care (UK).
Copyright © 2008, Royal College of General Practitioners.

All rights reserved. No part of this publication may be reproduced in any form (including photocopying or storing it in any medium by electronic means and whether or not transiently or incidentally to some other use of this publication) without the written permission of the copyright owner. Applications for the copyright owner’s written permission to reproduce any part of this publication should be addressed to the publisher.

PubMed Health. A service of the National Library of Medicine, National Institutes of Health.